enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. FDA approves Pfizer's new nasal spray treatment for migraines

   www.aol.com/news/fda-approves-pfizers-nasal...

   The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) -- the first and only migraine treatment of its kind to be offered in nasal spray.

3. Ubrogepant - Wikipedia

   en.wikipedia.org/wiki/Ubrogepant

   Ubrogepant, sold under the brand name Ubrelvy, is a medication used for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. [4] [5] It is not indicated for the preventive treatment of migraine. [6] Ubrogepant is a small-molecule calcitonin gene-related peptide receptor antagonist.

4. This New Nasal Spray Could Provide Migraine Relief in ... - AOL

   www.aol.com/lifestyle/nasal-spray-could-migraine...

   Zavzpret is a new nasal spray to treat migraine headaches in adults. But how does the medication work and who should try the new FDA-approved medication?

5. 17 expert-approved ways to relieve migraine pain ... - AOL

   www.aol.com/news/17-expert-approved-ways-relieve...

   Part of creating a treatment strategy for migraine involves reducing and preventing central sensitization because when that kicks in, "it's harder to treat migraines and certain medications don't ...

6. Lasmiditan - Wikipedia

   en.wikipedia.org/wiki/Lasmiditan

   The FDA approved lasmiditan primarily based on data from two clinical trials, Trial 1 (# NCT02439320) and Trial 2 (#NCT02605174) of 4439 subjects with migraine headaches with or without aura. [19] Trials were conducted at 224 sites in the United States, the United Kingdom, and Germany. [19] The FDA approved the drug in October 2019. [19]

7. Management of migraine - Wikipedia

   en.wikipedia.org/wiki/Management_of_migraine

   Rescue treatment involves acute symptomatic control with medication. [4] Recommendations for rescue therapy of migraine include: (1) migraine-specific agents such as triptans, CGRP antagonists, or ditans for patients with severe headaches or for headaches that respond poorly to analgesics, (2) non-oral (typically nasal or injection) route of administration for patients with vomiting, (3) avoid ...